Fatigue, Anhedonia and Cardiac Prognostic Markers in Depressed Patients With Coronary Heart Disease

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Depression doubles the risk of death in patients with coronary heart disease (CHD), but so far, there is insufficient evidence that we can reduce the risk of death by treating depression. This study will investigate the cardiac risk markers that are associated with depression symptoms that remain despite treatment, and identify potential targets for their treatment. The results of the study will inform the development of more effective interventions to improve both depression and survival in patients with CHD.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients seen at the Washington University Medical Center with coronary heart disease (CHD) documented by coronary angiography or history of acute coronary syndrome (ACS).

• On a stable medication regimen (only minor changes in drug or dosage in last 30 days) are eligible for recruitment.

• Meet the diagnostic criteria for a depressive disorder, score ≥ 14 on the Beck Depression Inventory (BDI-II), and not meet any exclusion criteria.

Locations
United States
Missouri
Washington University
RECRUITING
St Louis
Contact Information
Primary
Patricia A Herzing, RN
herzingp@wustl.edu
314-286-1360
Backup
Jessica L Winker, MPH
jessica.winker@wustl.edu
314-286-1313
Time Frame
Start Date: 2020-12-01
Estimated Completion Date: 2025-05-31
Participants
Target number of participants: 175
Treatments
Patients with medically stable coronary heart disease and Depressive Disorder
Authors
Robert M Carney
Related Therapeutic Areas
Sponsors
Leads: Washington University School of Medicine

This content was sourced from clinicaltrials.gov